title: Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation. .
abstract: Bullous pemphigoid (BP) is an autoimmune blistering skin disease characterized by the presence of autoantibodies to normal components of the hemidesmosome (BPAg1 and BPAg2). Histology of skin lesions demonstrate a subepidermal vesicle and a predominantly eosinophilic dermal cellular infiltrate. Interleukin 5 (IL-5) plays a major role in eosinophil recruitment and function. Using an ELISA, we investigated the levels of IL-5 in the sera and blister fluid of BP patients with active disease and those in prolonged clinical remission treated with intravenous immunoglobulin, and compared it to that in normal controls. Significantly increased levels of IL-5 were detected in the serum and particularly the blister fluid of patients with active disease (P=0.0043) when compared to levels in normal controls. There was no significant difference in IL-5 levels in patients in prolonged clinical remission compared to normal control serum. In an immunoblot assay, using bovine gingival lysate as substrate, we determined the presence of IgG and IgE autoantibodies specific to basement membrane zone proteins in blister fluid and serum of BP patients. IgG autoantibodies to BPAg1 and BPAg2 were detected in both blister fluid and serum of patients, whereas IgE autoantibodies, in much lower titers, were detected to only BPAg1. Elevated levels of blood and tissue eosinophilia were observed in these patients. Based on these data, we present a preliminary hypothesis for the initiation, progression and localization of blister formation in BP.
authors.affiliation: Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, Boston, MA, USA
authors.forename: L
authors.initials: L
authors.lastname: Engineer
authors.forename: K
authors.initials: K
authors.lastname: Bhol
authors.forename: S
authors.initials: S
authors.lastname: Kumari
authors.lastname: Razzaque Ahmed A
mesh_terms: D001323:Autoantibodies / Q000378:metabolism*; D001485:Basement Membrane / Q000276:immunology*; D001768:Blister / Q000276:immunology; D016022:Case-Control Studies; D004802:Eosinophilia / Q000276:immunology; D004804:Eosinophils / Q000276:immunology*; D006801:Humans; D007073:Immunoglobulin E / Q000378:metabolism; D007074:Immunoglobulin G / Q000378:metabolism; D015848:Interleukin-5 / Q000097:blood / Q000378:metabolism*; D010391:Pemphigoid, Bullous / Q000276:immunology*; D012867:Skin / Q000276:immunology
chemical_list: D001323:Autoantibodies; D007074:Immunoglobulin G; D015848:Interleukin-5; D007073:Immunoglobulin E